1. Kruczek, Kamil, Qu, Zepeng, Welby, Emily, Brooks, Brian P, Swaroop, Anand. 2022. In vitro modeling and rescue of ciliopathy associated with IQCB1/NPHP5 mutations using patient-derived cells. In Stem cell reports, 17, 2172-2186. doi:10.1016/j.stemcr.2022.08.006. https://pubmed.ncbi.nlm.nih.gov/36084637/
2. Sen, Sagnik, Fabozzi, Lorenzo, Fujinami, Kaoru, Georgiou, Michalis, Michaelides, Michel. 2024. IQCB1 (NPHP5)-Retinopathy: Clinical and Genetic Characterization and Natural History. In American journal of ophthalmology, 264, 205-215. doi:10.1016/j.ajo.2024.03.009. https://pubmed.ncbi.nlm.nih.gov/38522724/
3. Wang, Junwen, Li, Shiqiang, Jiang, Yi, Wang, Panfeng, Zhang, Qingjiong. 2023. Pathogenic Variants in CEP290 or IQCB1 Cause Earlier-Onset Retinopathy in Senior-Loken Syndrome Compared to Those in INVS, NPHP3, or NPHP4. In American journal of ophthalmology, 252, 188-204. doi:10.1016/j.ajo.2023.03.025. https://pubmed.ncbi.nlm.nih.gov/36990420/
4. Oh, Annie, Pearce, Jacqueline W, Gandolfi, Barbara, Belknap, Ellen B, Lyons, Leslie A. 2017. Early-Onset Progressive Retinal Atrophy Associated with an IQCB1 Variant in African Black-Footed Cats (Felis nigripes). In Scientific reports, 7, 43918. doi:10.1038/srep43918. https://pubmed.ncbi.nlm.nih.gov/28322220/